RegeneRx Biopharmaceuticals PEG Ratio

RegeneRx Biopharmaceuticals (RGRX) currently reports a PEG ratio of 0.0. That is below the Healthcare sector average of 12.15. Use the charts on this page to explore RegeneRx Biopharmaceuticals's PEG ratio history and peer comparisons.

RegeneRx Biopharmaceuticals's PEG ratio of 0.0 is lower than the Healthcare sector average of 12.15. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates RegeneRx Biopharmaceuticals's market price to a fundamental measure such as earnings, sales, or book value. At 0.0, RGRX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 0.0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 12.15. From there, open related valuation or income-statement pages for RegeneRx Biopharmaceuticals, and consider following RGRX for alerts when major investors trade the stock.

RegeneRx Biopharmaceuticals is classified in the Healthcare sector. On PEG ratio, it currently shows 0.0 versus a sector average near 12.15. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RGRX with unrelated industries.